Nicole Ferguson, DO
Family Medicine · Des Moines, IANPI 1194245506
Payments from drug & device makers
Across 188 payments — averaging $13.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$683
- GSK$292
- Boehringer Ingelheim$175
- AbbVie$171
- Lilly USA, LLC$150
- Bayer$133
- plus $893 from 22 others
What the payments were for
- Food & beverage$2,497100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 83 | $683 |
| GSK | 19 | $292 |
| Boehringer Ingelheim | 9 | $175 |
| AbbVie | 9 | $171 |
| Lilly USA, LLC | 10 | $150 |
| Bayer | 7 | $133 |
| AstraZeneca | 7 | $104 |
| Novartis | 6 | $99 |
| Astellas Pharma US Inc | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Amgen | 5 | $67 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Genentech USA, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 1 | $38 |
| Novo Nordisk | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Sanofi Pasteur Inc. | 2 | $34 |
| Exact Sciences | 1 | $33 |
| Amarin Pharma, Inc. | 2 | $31 |
| Insulet Corporation | 1 | $28 |
| Abiomed | 1 | $25 |
| Merck | 1 | $22 |
| Kerecis Limited | 1 | $19 |
| Abbott | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Coopersurgical, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
How this compares
$2,497 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $65,458 |
| JardianceEmpagliflozin | 66 | $61,578 |
| EliquisApixaban | 58 | $54,095 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $22,034 |
| TrulicityDulaglutide | 16 | $17,764 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $17,342 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $16,373 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 21 | $15,535 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $12,347 |
| MyrbetriqMirabegron | 23 | $10,204 |
| Dexlansoprazole DrDexlansoprazole | 34 | $8,142 |
| Gabapentin | 130 | $1,927 |
| Bupropion XlBupropion Hcl | 42 | $1,708 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $1,685 |
| SynthroidLevothyroxine Sodium | 23 | $1,511 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat | $175 | $77,11287 claims |
| Novo NordiskOzempic | $38 | $65,45869 claims |
| PfizerEliquis | $683 | $54,09558 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $292 | $34,38146 claims |
| Lilly USA, LLCTrulicity | $150 | $17,76416 claims |
| AstraZenecaBreztri Aerosphere | $104 | $16,37325 claims |
| Astellas Pharma US IncMyrbetriq | $82 | $10,20423 claims |
| AbbVieSynthroid | $171 | $1,51123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Des Moines
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
- Dylan LoweDes Moines$105K
- Lisa KlockDes Moines$9K
- Kristin GisselmanDes Moines$8K
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.